mRNA decapping enzyme2 DCP2 expression correlates with progression and prognosis of hepatocellular carcinoma
Abstract mRNA decapping enzyme 2 (DCP2) is a key regulator of mRNA degradation, influencing RNA metabolism and gene expression. While implicated in various diseases, its role in Hepatocellular carcinoma (HCC) remains unclear. This study explores DCP2 as a potential biomarker for HCC through bioinfor...
Saved in:
| Main Authors: | Tianyi Huang, Rui Wang, Cuihua Lu, Jiaying Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-10308-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Creatine mitigates neurogenesis impairment caused by defective DcpS decapping
by: Jun Yang, et al.
Published: (2025-05-01) -
The miRNA‐mRNA Regulatory Network in Human Hepatocellular Carcinoma by Transcriptomic Analysis From GEO
by: Razieh Heidari, et al.
Published: (2025-01-01) -
Integration of Earth-based materials in 3D concrete printing (3DCP): Physico-chemical and Technological characterization
by: Oulkhir Fatima-Zahra, et al.
Published: (2025-01-01) -
Distinct Roles of HHLA2 and PD-L1 in the Immune Cell and Prognosis of Hepatocellular Carcinoma
by: Wang CH, et al.
Published: (2025-07-01) -
N6-methyladenosine-modified circDCP2 promotes carbon black nanoparticle-induced malignancy in human bronchial epithelial cells via PI3K-AKT pathway and macrophage homeostasis
by: Shulin Qin, et al.
Published: (2025-08-01)